Cytological history of cases of invasive cervical cancer diagnosed in France in 2006

被引:31
作者
Boulanger, J. -C. [1 ]
Fauvet, R. [1 ]
Urrutiaguer, S. [1 ]
Drean, Y. [1 ]
Sevestre, H. [2 ]
Ganry, O. [3 ]
Bergeron, C. [4 ]
Gondry, J. [1 ]
机构
[1] CHU Amiens, Ctr Gynecol & Obstet, F-80054 Amiens 1, France
[2] CHU Amiens, Serv Anatomopathol, F-80000 Amiens, France
[3] CHU Amiens, Serv Epidemiol & Biostat, F-80000 Amiens, France
[4] Lab Pasteur Cerba, F-95066 Cergy Pontoise 9, France
来源
GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2007年 / 35卷 / 09期
关键词
invasive cervical cancer; screening; papanicolaou (pap) smear; false negative pap smear;
D O I
10.1016/j.gyobfe.2007.07.019
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective. - After a significant decrease of the incidence of invasive cervical cancer with the practice of cytologic screening, the numbers remain the same nowadays. To explain the reasons for that, we performed a survey of the cases of invasive cervical cancer observed in France in 2006. Material and method. - A questionnaire about screening practice was sent to every member of the French Society of Colposcopy (SFCPCV) to fill out for every invasive cancer diagnosed in 2006. Results. - Five hundred and twenty-four cases were collected: 2/3 of them never had a pap smear or were under screened. Indeed 27% had a labelled normal smear in the last three years. Discussion and conclusion. - As many others, this study shows that the first risk factor remains the lack of screening. But, 27% are false negative pap smears and it is even 45% under 45 years. The first thing to do is an organized mass screening but the increasing number of false negatives raises the question of the quality control of the cytology, or else to turn to a new test. (C) 2007 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:764 / 771
页数:8
相关论文
共 23 条
  • [1] Clinical applications of HPV testing: A summary of meta-analyses
    Arbyn, Marc
    Sasieni, Peter
    Meijer, Chris J. L. M.
    Clavel, Christine
    Koliopoulos, George
    Dillner, Joakim
    [J]. VACCINE, 2006, 24 : 78 - 89
  • [2] Boulanger J-C, 2004, Gynecol Obstet Fertil, V32, P218, DOI 10.1016/j.gyobfe.2004.01.013
  • [3] Why do women still develop cancer of the cervix despite the existence of a national screening programme?
    Brinkmann, D
    Gladman, MA
    Norman, S
    Lawton, FG
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 119 (01) : 123 - 124
  • [4] CAMATTE S, 2005, INCIDENCE MORTALITE, P35
  • [5] CUCHEROUSSET J, 2003, GYNECOL OBSTET PRATI, P153
  • [6] DARGENT D, 1992, CONTRACEPT FERTIL S, V20, P644
  • [8] EXBRAYAT C, 2003, EVOLUTION INCIDENCE, P107
  • [9] THE SCREENING HISTORIES OF WOMEN WITH INVASIVE CERVICAL-CANCER, CONNECTICUT
    JANERICH, DT
    HADJIMICHAEL, O
    SCHWARTZ, PE
    LOWELL, DM
    MEIGS, JW
    MERINO, MJ
    FLANNERY, JT
    POLEDNAK, AP
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (06) : 791 - 794
  • [10] LINDQVIST PG, 2007, IN PRESS EUR J OBSTE